IV therapy clinics are cash-pay medical businesses that administer intravenous vitamin, hydration, and nutrient infusions for wellness, recovery, and preventive health purposes. The industry emerged from concierge medicine and surged during and after COVID-19 as consumers embraced proactive wellness spending. Operating at the intersection of healthcare and lifestyle, these clinics face a patchwork of state regulations governing medical supervision, scope of practice, and compounded pharmaceutical use that creates both competitive barriers and compliance risk.
Who buys these: Private equity-backed med spa rollup platforms, individual entrepreneurs with healthcare backgrounds, physician groups looking to diversify revenue, wellness entrepreneurs seeking cash-pay medical businesses, and small PE firms targeting fragmented wellness verticals
3–5.5×
Typical EBITDA multiple
$1M–$5M
Revenue range
Growing
Market trend
SBA Eligible
7(a) financing available
Minimum $500K EBITDA preferred, established medical director agreement with transferable structure, at least 2 years of operating history, documented clinical protocols, cash-pay revenue model with no insurance dependency, and a proven recurring customer base with membership programs
Get Deal Flow In Your Inbox
New IV Therapy Clinic acquisition targets delivered weekly — free to join.
Key items to investigate when evaluating a IV Therapy Clinic acquisition
Seller Intelligence
Who sells IV Therapy Clinic businesses?
Owner-operator nurses, nurse practitioners, or physicians who founded clinics during the wellness boom, entrepreneurs who built lifestyle businesses seeking liquidity, and multi-location operators looking to exit ahead of regulatory tightening or market saturation
Typical exit timeline: 12–18 months
IV Therapy Clinic businesses in the $1M–$5M revenue range typically sell for 3–5.5× EBITDA. Minimum $500K EBITDA preferred, established medical director agreement with transferable structure, at least 2 years of operating history, documented clinical protocols, cash-pay revenue model with no insurance dependency, and a proven recurring customer base with membership programs
IV Therapy Clinic businesses typically trade at 3–5.5× EBITDA in the lower middle market. The market is highly fragmented with growing demand, which supports premium multiples.
IV Therapy Clinic businesses are SBA 7(a) eligible, making them accessible to first-time buyers. Full asset purchase with 10–20% seller earnout tied to 12-month post-close revenue retention
Key due diligence areas include: Medical director agreement structure, transferability, and state compliance with corporate practice of medicine regulations; Nurse/provider licensing, scope of practice documentation, and malpractice insurance history; Customer concentration, membership retention rates, and average revenue per visit trends; Supplier agreements for IV supplies, pharmaceutical procurement, and compounding pharmacy relationships; Regulatory compliance including state health department licensing, OSHA protocols, and FDA guidelines on compounded infusions.
Related Searches
DealFlow OS surfaces acquisition targets, scores seller motivation, and generates outreach — all in one place.
Start finding deals — freeNo credit card required
For Buyers
For Sellers